PainReform Ltd. (PRFX)
USD 2.36
(2.61%)
USD 2.36
(2.61%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -7.95 Million USD | -94.09% |
| 2022 | -4.09 Million USD | 75.23% |
| 2021 | -16.53 Million USD | -5.49% |
| 2020 | -15.67 Million USD | -399.64% |
| 2019 | 5.23 Million USD | 16.79% |
| 2018 | 4.48 Million USD | 27.24% |
| 2017 | 3.52 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -2.73 Million USD | 36.09% |
| 2024 Q1 | -4.26 Million USD | 46.39% |
| 2023 Q4 | -7.95 Million USD | -6.61% |
| 2023 FY | -7.95 Million USD | -94.09% |
| 2023 Q3 | -7.45 Million USD | -45.13% |
| 2023 Q2 | -5.13 Million USD | 36.89% |
| 2023 Q1 | -8.14 Million USD | -98.75% |
| 2022 Q1 | -15.41 Million USD | 6.77% |
| 2022 FY | -4.09 Million USD | 75.23% |
| 2022 Q4 | -4.09 Million USD | 40.83% |
| 2022 Q3 | -6.92 Million USD | 50.0% |
| 2022 Q2 | -13.84 Million USD | 10.2% |
| 2021 FY | -16.53 Million USD | -5.49% |
| 2021 Q1 | -19.42 Million USD | -23.9% |
| 2021 Q3 | -18.33 Million USD | -3.09% |
| 2021 Q4 | -16.53 Million USD | 9.82% |
| 2021 Q2 | -17.78 Million USD | 8.43% |
| 2020 FY | -15.67 Million USD | -399.64% |
| 2020 Q4 | -15.67 Million USD | 0.0% |
| 2020 Q2 | 6.25 Million USD | 564.19% |
| 2020 Q1 | 941 Thousand USD | -82.01% |
| 2019 Q3 | 5.23 Million USD | 7.72% |
| 2019 Q2 | 4.85 Million USD | 0.0% |
| 2019 Q1 | 4.85 Million USD | 8.42% |
| 2019 Q4 | 5.23 Million USD | 0.0% |
| 2019 FY | 5.23 Million USD | 16.79% |
| 2018 Q3 | 4.48 Million USD | 0.0% |
| 2018 Q4 | 4.48 Million USD | 0.0% |
| 2018 FY | 4.48 Million USD | 27.24% |
| 2018 Q1 | 187 Thousand USD | 0.0% |
| 2017 FY | 3.52 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Esperion Therapeutics, Inc. | 458.69 Million USD | 101.733% |
| Theratechnologies Inc. | 24.87 Million USD | 131.965% |
| Safety Shot Inc | -2.28 Million USD | -248.016% |
| Cosmos Health Inc. | 8.59 Million USD | 192.541% |
| Cronos Group Inc. | -663.32 Million USD | 98.801% |
| Ironwood Pharmaceuticals, Inc. | 623.38 Million USD | 101.275% |
| Kala Pharmaceuticals, Inc. | -14.57 Million USD | 45.443% |
| Organogenesis Holdings Inc. | 15.01 Million USD | 152.954% |
| Universe Pharmaceuticals INC | 197.2 Thousand USD | 4131.256% |
| ProPhase Labs, Inc. | 19.23 Million USD | 141.34% |
| Sonoma Pharmaceuticals, Inc. | -2.52 Million USD | -215.476% |
| Dynavax Technologies Corporation | 106.63 Million USD | 107.455% |
| Radius Health, Inc. | 359.28 Million USD | 102.213% |
| China SXT Pharmaceuticals, Inc. | -9.42 Million USD | 15.692% |
| Alvotech | 1.06 Billion USD | 100.747% |
| Sunshine Biopharma, Inc. | -15.63 Million USD | 49.151% |
| Alpha Teknova, Inc. | 1.97 Million USD | 502.736% |
| Intra-Cellular Therapies, Inc. | -130.82 Million USD | 93.923% |
| SCYNEXIS, Inc. | -19.35 Million USD | 58.915% |
| Harrow Health, Inc. | 116.41 Million USD | 106.829% |
| Biofrontera Inc. | 4.05 Million USD | 296.006% |
| DURECT Corporation | -7.65 Million USD | -3.867% |
| Supernus Pharmaceuticals, Inc. | -33.52 Million USD | 76.288% |
| ANI Pharmaceuticals, Inc. | 94.2 Million USD | 108.439% |
| OptiNose, Inc. | 58.06 Million USD | 113.692% |
| RedHill Biopharma Ltd. | -5.18 Million USD | -53.296% |
| Aquestive Therapeutics, Inc. | 74.95 Million USD | 110.607% |
| Cumberland Pharmaceuticals Inc. | 106.85 Thousand USD | 7539.71% |
| SIGA Technologies, Inc. | -148.68 Million USD | 94.653% |
| Lifecore Biomedical, Inc. | 121.89 Million USD | 106.522% |
| Shineco, Inc. | 29.29 Million USD | 127.142% |
| Phibro Animal Health Corporation | 454.84 Million USD | 101.748% |
| Procaps Group S.A. | 242.93 Million USD | 103.273% |
| TherapeuticsMD, Inc. | 3.67 Million USD | 316.15% |
| Regencell Bioscience Holdings Limited | -2.9 Million USD | -174.003% |
| Viatris Inc. | 17.13 Billion USD | 100.046% |
| Sunshine Biopharma, Inc. | -15.63 Million USD | 49.151% |
| Rockwell Medical, Inc. | 4.45 Million USD | 278.411% |
| Incannex Healthcare Limited | -5.48 Million USD | -44.941% |
| Aytu BioPharma, Inc. | -4.87 Million USD | -63.01% |
| Tilray Brands, Inc. | 158.97 Million USD | 105.001% |
| Collegium Pharmaceutical, Inc. | 435.33 Million USD | 101.826% |
| PetIQ, Inc. | 351.93 Million USD | 102.259% |
| Silver Spike Investment Corp. | -32.61 Million USD | 75.622% |
| Neurocrine Biosciences, Inc. | 177.3 Million USD | 104.484% |
| Journey Medical Corporation | -9.7 Million USD | 18.117% |
| Alimera Sciences, Inc. | 55.3 Million USD | 114.374% |
| Petros Pharmaceuticals, Inc. | -5.06 Million USD | -57.103% |
| Assertio Holdings, Inc. | -32.52 Million USD | 75.56% |
| Shuttle Pharmaceuticals Holdings, Inc. | -1.48 Million USD | -434.015% |
| Embecta Corp. | 1.31 Billion USD | 100.606% |
| Cyclo Therapeutics, Inc. | -8.21 Million USD | 3.208% |
| Procaps Group, S.A. | 242.93 Million USD | 103.273% |
| Avadel Pharmaceuticals plc | 4.21 Million USD | 288.523% |
| Hempacco Co., Inc. | 13.61 Million USD | 158.393% |
| Talphera, Inc. | -5.72 Million USD | -38.962% |
| Pacira BioSciences, Inc. | 432.74 Million USD | 101.837% |
| Alvotech | 1.06 Billion USD | 100.747% |
| Lantheus Holdings, Inc. | -96.71 Million USD | 91.78% |
| Kamada Ltd. | -46.43 Million USD | 82.878% |
| Indivior PLC | -33.95 Million USD | 76.585% |
| Currenc Group, Inc. | -16.57 Million USD | 52.031% |
| Evoke Pharma, Inc. | 260.57 Thousand USD | 3150.957% |
| Flora Growth Corp. | -713 Thousand USD | -1015.007% |
| Cyclo Therapeutics, Inc. | -8.21 Million USD | 3.208% |
| Evolus, Inc. | 63.7 Million USD | 112.479% |
| HUTCHMED (China) Limited | -197.45 Million USD | 95.974% |
| Amphastar Pharmaceuticals, Inc. | 479.11 Million USD | 101.659% |
| Akanda Corp. | 3.9 Million USD | 303.59% |